Chapter 11
Miniplegia: Biological Basis, Surgical Techniques, and Clinical Results
Giuseppe D'Ancona MD,
Hratch Karamanoukian MD,
Luigi Martinelli MD,
Michael O. Sigler MD,
Tomas A. Salerno MD,
Giuseppe D'Ancona MD
Search for more papers by this authorHratch Karamanoukian MD
Search for more papers by this authorLuigi Martinelli MD
Search for more papers by this authorMichael O. Sigler MD
Search for more papers by this authorTomas A. Salerno MD
Search for more papers by this authorGiuseppe D'Ancona MD,
Hratch Karamanoukian MD,
Luigi Martinelli MD,
Michael O. Sigler MD,
Tomas A. Salerno MD,
Giuseppe D'Ancona MD
Search for more papers by this authorHratch Karamanoukian MD
Search for more papers by this authorLuigi Martinelli MD
Search for more papers by this authorMichael O. Sigler MD
Search for more papers by this authorTomas A. Salerno MD
Search for more papers by this authorBook Editor(s):Tomas A. Salerno MD,
Marco Ricci MD,
Tomas A. Salerno MD
Professor and Chief, Division of Cardiothoracic Surgery, University of Miami, Jackson Memorial Hospital, Miami, Florida
Search for more papers by this authorMarco Ricci MD
Assistant Professor of Surgery, Division of Cardiothoracic Surgery, Staff Surgeon, Section of Pediatric Cardiac Surgery, University of Miami, Jackson Memorial Hospital, Miami, Florida
Search for more papers by this authorFirst published: 13 November 2003
Summary
This chapter contains sections titled:
-
Introduction
-
Miniplegia: rheologic and biologic issues
-
Miniplegia: perfusion technique
-
Miniplegia: clinical and experimental studies
-
Conclusion
References
- Feindel CM, Tait GA, Wilson G. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury. J Thorac Cardiovasc Surg 1984; 87: 585–95.
- Fremes SE, Christakis GT, Weisel RD et al. A clinical trial of blood and crystalloid cardioplegia. J Thorac Cardiovasc Surg 1984; 88: 726–41.
- Follette DM, Fey K, Buckberg GD et al. Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg 1981; 82: 221–38.
- Menasche P, Touchot B, Pradier F et al. Simplified method for delivering normothermic blood cardioplegia. Ann Thorac Surg 1993; 55: 177–8.
- Menasche P, Fleury JP, Veyssie L et al. Limitation of vasodilation associated with warm heart operation by a mini-cardioplegia delivery technique. Ann Thorac Surg 1993; 56: 1148–53.
- O'Neill MJ, Francalancia N, Wolf PD et al. Resistance differences between blood and crystalloid cardioplegic solutions with myocardial cooling. J Surg Res 1981; 30: 354–60.
- Sakai A, Miya J, Sohara Y et al. Role of red blood cells in the coronary microcirculation during cold blood cardioplegia. Cardiovasc Res 1988; 22: 62–6.
- Salerno TA, Houck JP, Barrozo CA et al. Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection. Ann Thorac Surg 1991; 51: 245–7.
- Rand PW, Lacombe E, Hunt HE et al. Viscosity of normal human blood under normothermic and hypothermic conditions. J Appl Physiol 1964; 19: 117–22.
- Hayashida N, Weisel RD, Shirai T et al. Tepid antegrade and retrograde cardioplegia. Ann Thorac Surg 1995; 59: 723–9.
- Liu X, Engelman RM, Rousou JA et al. Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion. Circulation 1994; 57: 177–82.
- Takemoto N, Kuroda H, Hamasaki T et al. Effect of magnesium and calcium on myocardial protection by cardioplegic solutions. Ann Thorac Surg 1994; 57: 177–82.
- Neethling WML, van de Heever JJ, Cooper S et al. Interstitial pH during myocardial preservation: assessment of five methods of myocardial preservation. Ann Thorac Surg 1993; 55: 420–6.
- Warner KG, Josa M, Butler MD. Regional changes in myocardial acid production during ischemic arrest: a comparison of sanguineous and asanguineous cardiople-gia. Ann Thorac Surg 1988; 45: 75–81.
- Rosenkranz ER, Okamoto F, Buckberg GD et al. Safety of prolonged aortic clamping with blood cardioplegia. II. Glutamate enrichment in energy-depleted hearts. J Thorac Cardiovasc Surg 1984; 88: 402–10.
- Lazar HL, Buckberg GD, Mangarano AM et al. Myo-cardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion. J Thorac Cardiovasc Surg 1980; 80: 350–9.
- Wallace AW, Ratcliffe MB, Nose PS et al. Effect of induction and reperfusion with warm substrate-enriched car-dioplegia on ventricular function. Ann Thorac Surg 2000 October; 70: 1301–7.
- Edwards R, Treasure T, Hossein-Nia M et al. A controlled trial of substrate-enhanced, warm reperfusion (“hot shot”) versus simple reperfusion. Ann Thorac Surg 2000; 69: 551–5.
- Le Houerou D, Singh AI, Romano M et al. Minimal hemodilution and optimal potassium use during normothermic aerobic arrest. Ann Thorac Surg 1992; 54: 815–16.
- Calafiore AM, Teodori G, Mezzetti A et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 1995; 59: 398–402.
- Velez DA, Morris CD, Budde JM et al. All-blood (mini-plegia) versus dilute cardioplegia in experimental surgical revascularization of evolving infarction. Circulation 2001; 104: I296–302.
- Yeatman M, Caputo M, Naravan P et al. Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization. Ann Thorac Surg 2002; 73: 112–18.
